Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone controlling appetite and blood sugar levels. Clinical trials show patients lose 10-15% of body weight when combined with lifestyle changes. Proper injection technique and dose management are essential for maximizing results and minimizing side effects.
How Semaglutide Injections Work for Weight Management
Semaglutide functions by activating receptors in your brain that regulate hunger and fullness signals. The medication slows the rate at which your stomach empties food into the small intestine, creating a prolonged feeling of satisfaction after meals. This dual action reduces calorie intake naturally without requiring willpower-dependent restriction.
The drug also improves your body's ability to process blood sugar by stimulating insulin release when glucose levels rise. For people managing type 2 diabetes alongside weight goals, this metabolic benefit addresses both conditions simultaneously. Research demonstrates sustained use leads to changes in food preferences, with patients reporting decreased cravings for high-calorie foods.
PlexusDx provides semaglutide injections from licensed 503A compounding pharmacies, ensuring consistent quality and potency across all doses. Your healthcare provider determines the appropriate starting dose and progression schedule based on your individual health profile and goals.
Understanding Semaglutide Dosing Schedules and Administration
Semaglutide injections are administered once weekly using a small, pre-filled pen that you inject under the skin. Most patients begin at a lower starting dose to allow their body to adjust, then gradually increase over several weeks. This gradual approach reduces nausea and other gastrointestinal side effects while your system acclimates to the medication.
The injection can be given in your abdomen, thigh, or upper arm—areas with adequate subcutaneous tissue. Rotating injection sites helps prevent lipohypertrophy, a condition where repeated injections in the same spot cause localized fat accumulation. Your PlexusDx healthcare team provides detailed instruction on proper injection technique during your initial consultation.
Most patients follow a weekly injection schedule, with dose adjustments occurring every 4 weeks based on tolerance and response. PlexusDx offers Compounded Semaglutide Injection starting at $149 per month with flat pricing regardless of your current dose level—your dose may need to go up, but your price won't.
Expected Weight Loss Results and Timeline with Semaglutide
Weight loss typically becomes noticeable within 4-8 weeks of starting semaglutide, though individual timelines vary based on genetics, diet, and activity level. Most patients experience gradual, consistent weight loss of 1-2 pounds per week when medication is combined with balanced nutrition and regular movement. Larger weight reductions accumulate over 3-6 months of consistent treatment.
Clinical studies found participants using semaglutide lost approximately 10-15% of their starting body weight over one year. Those who maintained dietary improvements and exercise routines achieved results at the higher end of this range. PlexusDx patients who undergo the Precision Peptide Genetic Test gain insights into 14 pathways affecting weight regulation, allowing personalized optimization of their treatment approach.
Results plateau when you reach your body's natural set point for weight maintenance. Continuing the medication helps sustain losses long-term, as studies show weight regain occurs when semaglutide is discontinued without lifestyle modifications. PlexusDx supports ongoing monitoring to ensure your treatment remains aligned with your evolving health goals.
Managing Side Effects and Optimizing Your Semaglutide Experience
The most common side effect is mild nausea, typically occurring during dose escalation phases and diminishing as your body adapts. Eating smaller, lower-fat meals reduces gastrointestinal discomfort significantly. Some patients experience mild constipation or diarrhea, manageable through dietary fiber adjustments and adequate hydration.
Staying hydrated throughout the day supports medication tolerance and prevents dehydration-related side effects. Avoiding greasy or high-sugar foods during your first weeks on semaglutide helps your digestive system adjust smoothly. Most patients report that side effects resolve within 2-4 weeks once their dose stabilizes.
Rare but serious side effects include severe abdominal pain or persistent vomiting—contact your healthcare provider immediately if these occur. PlexusDx provides continuous support through your treatment journey, with access to your prescriber for dose adjustments or side effect management. HSA and FSA accounts cover semaglutide injections, making treatment accessible across all states without requiring insurance or membership fees.
Personalized Semaglutide Treatment Through Genetic Insights
Your genetic makeup influences how effectively your body responds to semaglutide and other GLP-1 medications. Key genetic variants in the GLP1R gene (rs6923761) and FTO gene (rs9939609) affect appetite regulation and weight predisposition. The PlexusDx Precision Peptide Genetic Test identifies these and 150+ other genetic insights for just $99 after your first month of treatment.
Understanding your peptide pathways allows your PlexusDx provider to optimize your semaglutide protocol or consider combination therapies if needed. Some patients benefit from dual-compound approaches like GLP-Squared Injection when genetic analysis reveals multiple pathway involvement. This personalized approach dramatically improves long-term outcomes compared to one-size-fits-all treatment.
PlexusDx maps 14 distinct pathways and 49 peptides involved in weight regulation, appetite, and metabolism. This comprehensive genetic roadmap transforms your treatment from trial-and-error into precision medicine. Your PlexusDx provider uses these insights to select the ideal medication formulation and dosing strategy from the start.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How often do I inject semaglutide, and can I self-administer?
Semaglutide injections are administered once weekly using a pre-filled pen you use yourself, similar to insulin therapy. Most patients find self-injection simple after initial training from their PlexusDx healthcare provider. You rotate injection sites between your abdomen, thigh, and upper arm each week to prevent skin complications.
Does semaglutide dose increase affect the monthly price with PlexusDx?
No. PlexusDx Compounded Semaglutide Injection starts at $149 per month with flat pricing across all dose levels. Your dose may need to go up during your treatment progression, but your monthly cost remains consistent—a key advantage of PlexusDx's pricing model.
What clinical evidence supports semaglutide for weight loss?
Multiple Phase 3 trials demonstrate semaglutide produces 10-15% weight loss over one year when combined with lifestyle modifications. The medication also improves cardiovascular outcomes and blood sugar control in patients with type 2 diabetes. These results represent some of the most significant weight loss achievements in obesity treatment over the past decade.
Are there serious side effects I should watch for with semaglutide?
Most side effects are mild and temporary, resolving within 2-4 weeks. Severe abdominal pain, persistent vomiting, or signs of pancreatitis require immediate medical attention. PlexusDx provides continuous provider access to monitor your response and adjust your treatment if needed, ensuring safety throughout your therapy.
How does the PlexusDx Precision Peptide Genetic Test improve my semaglutide treatment?
The test identifies genetic variants in your GLP1R, FTO, MC4R, and GIPR genes that influence how your body responds to semaglutide. PlexusDx maps your 14 weight-regulation pathways and 150+ genetic insights for just $99 after your first month, enabling your provider to optimize your specific protocol or recommend alternative compounds like tirzepatide or GLP-Squared if indicated.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Kidney Health: Can You Take Ozempic If You Have Kidney Disease?
Ozempic Dosage Limits: Can I Take More Than 2 mg for Weight Loss or Diabetes?